Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Biote Pharmaceutical is a comprehensive high-tech pharmaceutical enterprise based in China that integrates research and development, manufacturing, and sales. The company focuses on a wide range of therapeutic areas including oncology, anti-infectives, cardiovascular diseases, and metabolic disorders. Biote Pharmaceutical operates several R&D centers and large-scale manufacturing bases, producing both generic drugs and innovative biologics. Their pipeline includes advanced modalities such as antibody-drug conjugates and monoclonal antibodies, alongside a robust portfolio of small molecule therapeutics. The company is recognized for its strong manufacturing capabilities and its commitment to providing high-quality, affordable medicines to the global market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Biotec Biotechnology.